CES2 and metabolic dysfunction-associated steatotic liver disease: Accordingly, we speculated that the HNF4α-CES2 pathway may be involved in the observed therapeutic effect of UC-MSCs on NAFLD, and then we measured the activity of the pathway among the experimental groups by qRT-PCR and western blot.